Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Nimenrix |
| Active Ingredients: | Neisseria meningitidis Group A polysaccharide, tetanus toxoid conjugate 5mcg Neisseria meningitidis Group C polysaccharide, tetanus toxoid conjugate 5mcg Neisseria meningitidis Group W135 polysaccharide, tetanus toxoid conjugate 5mcg Neisseria meningitidis Group Y polysaccharide, tetanus toxoid conjugate 5mcg |
| Dosage Form: | Powder for injection with diluent |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturers: | GlaxoSmithKline Biologicals SA, Wavre, Belgium Pfizer Manufacturing Belgium NV, Puurs, Belgium |
| Product: | Octreotide Depot |
| Active Ingredient: | Octreotide acetate 11.2mg equivalent to octreotide 10mg |
| Dosage Form: | Powder for injection with diluent |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Pharmathen International SA, Rodopi, Greece |
| Product: | Octreotide Depot |
| Active Ingredient: | Octreotide acetate 22.4mg equivalent to octreotide 20mg |
| Dosage Form: | Powder for injection with diluent |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Pharmathen International SA, Rodopi, Greece |
| Product: | Octreotide Depot |
| Active Ingredient: | Octreotide acetate 33.6mg equivalent to octreotide 30mg |
| Dosage Form: | Powder for injection with diluent |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Pharmathen International SA, Rodopi, Greece |
| Product: | Sabril |
| Active Ingredient: | Vigabatrin 500mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | Patheon France SA, Bourgoin-Jallieu, France |
Dated this 29th day of August 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).